- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07137455
Cardiac Electrogram Recording System Study for Arrhythmia Patients
This clinical trial focuses on evaluating a specialized medical device called the EDEN Intracardiac Electrogram Recording and Classifying System. This innovative technology is designed to record and analyze electrical signals from within the heart during standard medical procedures for patients with ventricular arrhythmias. The study aims to determine how accurately this automated system can classify heart tissue depth compared to classifications made by healthcare providers during electrophysiology procedures.
For patients and caregivers considering participation, it's important to understand that this research involves testing the device's performance rather than making diagnostic decisions about your condition. The EDEN system will be used alongside your medically necessary procedure, recording electrical patterns from different layers of the heart muscle. Researchers will compare the device's automated classifications with those made by the medical team to assess its accuracy in identifying whether signals come from the heart chamber, inner layer, middle layer, outer layer, or the pericardial space surrounding the heart.
The study will enroll approximately 50 adult participants who are already scheduled for necessary cardiac electrophysiology procedures, including mapping, ablation for ventricular arrhythmias, or conduction system pacing. Participation requires being at least 21 years old and able to provide informed consent. The research team, led by experienced cardiologists at the National Heart, Lung, and Blood Institute, will ensure patient safety throughout the study period from August 2025 through November 2026.
Cardiac arrhythmia research represents a critical frontier in cardiovascular medicine, with ventricular arrhythmias affecting millions of patients worldwide. These abnormal heart rhythms can significantly impact quality of life and may lead to serious complications if not properly managed. The development of advanced recording and classification systems like EDEN holds tremendous promise for improving how doctors understand and treat complex heart rhythm disorders. More accurate classification of intracardiac signals could eventually lead to better targeted treatments and improved outcomes for patients living with these challenging conditions.
Research in cardiac electrophysiology has evolved dramatically over recent decades, moving from basic rhythm monitoring to sophisticated mapping systems that create 3D models of the heart's electrical activity. This study contributes to that ongoing advancement by testing whether automated classification can match or potentially exceed human accuracy in determining signal depth within the heart wall. For patients, this type of research represents hope for future innovations that might make procedures more precise, reduce procedure times, and ultimately improve success rates for arrhythmia treatments.
The importance of such research extends beyond immediate clinical applications. Each study that advances our understanding of cardiac electrical activity contributes to the broader knowledge base that informs future device development, treatment protocols, and clinical guidelines. For caregivers supporting loved ones with heart rhythm disorders, participating in research represents an opportunity to contribute to medical progress that may benefit countless patients in the future. While the EDEN system is still in the testing phase, studies like this are essential steps toward validating new technologies that could eventually become standard tools in cardiac care.
Patients considering participation should discuss the study thoroughly with their healthcare team and the research coordinators. Understanding that no treatment decisions will be based solely on the research findings can provide reassurance, as the primary focus remains on evaluating the device's performance rather than altering clinical care. The research team includes both physicians and specialized nurses who can address any concerns and ensure participants fully understand what involvement entails before providing consent.
Upcoming Clinical Trials
-
NCT07826949Not yet recruitingGlioma | Brain Neoplasm | Recurrent High-Grade Gliomas
-
NCT07826962Not yet recruiting
-
NCT07826975Not yet recruiting
-
NCT07826988Not yet recruitingSickle Cell Disease | Vaso-occlusive Crisis
-
NCT07827001RecruitingBrain Cancer | CNS Cancer | Nervous System Cancer | Brain Cancer Metastatic
-
NCT07827027Not yet recruiting
-
NCT07827040RecruitingAdults | Low Vision Digital Assistance | Visual Impairments
-
NCT07827053Not yet recruitingPancreatic Ductal Adenocarcinoma (PDAC)
-
NCT07827066Not yet recruitingSmoking Cessation | AI Agent | Early-Stage Cancer
-
NCT07827131Not yet recruiting